Abstract: An etching solution, a method of surface modification of a semiconductor substrate and a method of forming shallow trench isolation are provided. The etching solution is used for surface modifying the semiconductor substrate. The etching solution includes an oxidant and an oxide remover. The semiconductor substrate is oxidized to a semiconductor oxide by the oxidant, and the oxide remover subtracts the semiconductor oxide.

Abstract: Trisubstituted heteroaromatic compounds having the structure are provided, wherein X is C or N; A and B are each independently CH or N, with the proviso that A and B cannot both be CH; R1 is Ar-L-; R2 is hydrogen or alkyl; or R1 and R2 can be joined together to form a 4- to 7-membered cycloheteroalkyl ring; R3 to R8, Ar and L are as defined herein. A method for using these compounds to treat diseases associated with abnormal bone or mineral homeostasis is also provided.

Abstract: A system includes a mounting device (200), a detecting device (100), and a circuit (300). The mounting device includes a base (210), and a mounting head (220) opposite to the base. The detecting device is fixed on the base, and includes a shell (110) comprising a cavity (112) therein, a probe (130) fixed in the cavity and protruding towards the through hole, and a plug (150) having a pin (152) made of conductive materials. The shell further includes an opening (118) communicating with the cavity, and a through hole (114) formed opposite to the mounting head and communicating with the cavity. The pin is connected to the probe through the opening. The circuit includes a PLC circuit (320), and a power supply (310) connected with the PLC circuit. The pin connects with one of the PLC circuit and power circuit, and the mounting head connects with the remaining one.

Abstract: The present invention provides a gel-casting module, a main electrophoresis assembly, a casting stand for the main electrophoresis assembly and an electrophoresis tank.

Abstract: Compounds are provided which are antagonists of the calcium sensing receptor, and have the general formula wherein m is 0, 1, 2, 3 or 4; each X is independently selected from the group consisting of hydrogen, halo, cyano, nitro, OCF3, hydroxy, amino, carboxyl, alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, haloalkyl, alkoxy, alkoxycarbonylalkyl, hydroxycarbonylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkylalkyl, R1O, R1R2N, R1OCO, R1CO, R1R2NCO, R1R2NCONR2a, R1OCONR2a, R1CONR2a, R1S, R1SO, R1SO2, R1R2NSO2, R1R2NSO2NR2a, and R1SO2NR2a; R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; R2 and R2a are the same or different and are independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; n is 1, 2, or 3; W is O or H,R3; R3 is hydrogen or hydroxyl; Ar is a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl g

Abstract: An automatic packaging system is provided. The automatic packaging system includes a user interface, a selection-controlling module, an alarm-controlling module, and a package module. The user interface is for receiving user input. The selection-controlling module is for enabling and controlling a vibrating plate to select parts according to the user input, and generating a detection signal. The alarm-controlling module is for generating a package signal according to the detection signal and the user input. The package module is for packaging the parts according to the package signal.

Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.

Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.

Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.

Abstract: Provided herein are multi-stage broadband amplifier configured to achieve a high gain-bandwidth product in a non-distributed architecture and methods for designing the same. The broadband amplifier can include an input stage having a broadband matching unit and an input buffer unit, a gain stage having an RLC network and a amplifier unit and an output stage having a common collector amplifier and an RC compensation unit.

Abstract: A compound of formula I wherein X, R1, R2a, R3a, R3b, R4a, R4b, R4c and R5 are defined herein.

Abstract: A compound of formula I wherein A, X, q, R1, R2a, R2b, R2c, R3a, and R3b are defined herein.

Abstract: Methods and materials involving 28-epirapamycin analogs are disclosed.

Abstract: The present invention relates to modulators of the calcium sensing receptor having the formula I wherein Ar1, X, n, R1, R2, R3 and Q are as defined herein.

Abstract: Rapamycin derivatives containing substituents at C-28 in the epi orientation relative to rapamycin are disclosed, together with methods for their preparation and use, e.g. for regulation of biological phenomena in engineered cells. The compounds may contain optional additional modifications relative to rapamycin, as disclosed herein.

Abstract: In this application is disclosed a resin additive composition which can by produced by precipitating a calix(n+m+l)arene represented by the following general formula (2) and in a dissolved state together with or at the same time at least one functional ingredient selected from the group consisting of various water-soluble or hydrophilic resin flam-retardants, resin thermal stabilizers and resin curing agents, and in a dissolved or suspended state. This resin additive composition has a good affinity for organic polymers such as polyolefin and the like, which allows the functional ingredient(s) to be dispersed homogeneously in the resin. Therefore are provided high-performance resin compositions comprising various functional ingredient(s).

Abstract: Substituted benzoxazine and 3,4-dihydrobenzoxazine derivatives possessing activity as estrogen receptor beta (ER?) modulators are provided which have the structure of formula I wherein the substitutents are as described herein. In addition, a method is provided for preventing, inhibiting or treating the progression or onset of pathological conditions associated with the estrogen receptor and to pharmaceutical compositions containing such compounds.

Abstract: To prevent a furnace in a semiconductor process from temperature and gas excursion, a paddle and spike thermal couples arranged on the sidewall of the tube and adjacent to the heater, respectively, are connected to a temperature controller to regulate the heater, and a mass controller adjusts the gas flow injected to the tube. In the method, the spike thermal couple, peddle thermal couple and zero point of the mass flow controller are checked to maintain within a first and second temperature ranges and a first gas flow speed range, respectively, and after wafers are loaded and temperature is ramped up, the peddle thermal couple and mass flow controller are checked again to maintain within a third temperature range and second gas flow speed range.

Abstract: Methods and materials involving 28-epirapamycin analogs are disclosed.

Abstract: The present invention relates to novel fluorescent dyes, novel fluorogenic and fluorescent reporter molecules and new enzyme assay processes that can be used to detect the activity of caspases and other enzymes involved in apoptosis in whole cells, cell lines and tissue samples derived from any living organism or organ. The reporter molecules and assay processes can be used in drug screening procedures to identify compounds which act as inhibitors or inducers of the caspase cascade in whole cells or tissues. The reagents and assays described herein are also useful for determining the chemosensitivity of human cancer cells to treatment with chemotherapeutic drugs. The present invention also relates to novel fluorogenic and fluorescent reporter molecules and new enzyme assay processes that can be used to detect the activity of type 2 methionine aminopeptidase, HIV protease, adenovirus protease, HSV-1 protease, HCMV protease and HCV protease.